Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.

NCT ID: NCT05822622

Last Updated: 2023-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-29

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of our study to determine the demography, relation between patients with heart failure with preserved ejection fraction and those with nonalcoholic fatty liver disease in Sohag university hospital.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

type of the study cross sectional study to study the relationship between heart failure with preserved ejection fraction and nonalcoholic fatty liver disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure With Preserved Ejection Fraction Non Alcoholic Fatty Liver

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HFpEF(heart failure with preserved ejection fraction)

chronic heart failure with echocardiographic finding of LVEF (left ventricular ejection fraction) equal or more than 50% , diagnostic test :Abdominal ultrasound and transient elastography for detecting non alcoholic fatty liver disease .

echocardiography

Intervention Type OTHER

to determine finding of heart failure with preserved ejection fraction and non alcoholic fatty liver disease

NAFLD(non alcoholic fatty liver disease)

ultrasound and transient elastographic finding of fatty liver disease, diagnostic test :echocardiography to determine heart failure with preserved ejection fraction .

echocardiography

Intervention Type OTHER

to determine finding of heart failure with preserved ejection fraction and non alcoholic fatty liver disease

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

echocardiography

to determine finding of heart failure with preserved ejection fraction and non alcoholic fatty liver disease

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

abdominal ultrasound and transient elastography

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

clinical diagnosis of nonalcoholic fatty liver disease. -

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Asmaa Elsayed Khalifa

resident of internal medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aml K Ahmed, A professor

Role: STUDY_CHAIR

Sohag University

Alshimaa L Hamed, lecturer

Role: STUDY_CHAIR

Sohag University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Asmaa elsayed khalifa

Sohag, El Monshah, Egypt

Site Status

Asmaa E khalifa

Sohag, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Asmaa E khalifa, resident

Role: CONTACT

01021344185

Usama A Arafa, professor

Role: CONTACT

01063064007

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Asmaa E khalifa, resident

Role: primary

01021344185

Usama A Arafa, professor

Role: backup

01063064007

Asmaa E khalifa, Dr

Role: primary

01021344185

Usama A Arafa, prof

Role: backup

01063064007

References

Explore related publications, articles, or registry entries linked to this study.

Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017 Apr;3(1):7-11. doi: 10.15420/cfr.2016:25:2.

Reference Type RESULT
PMID: 28785469 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-23-02-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cohort of Heart Failure Patients
NCT03422991 COMPLETED NA
Uncertainty in HFrEF Patients
NCT05632198 COMPLETED
The Use of Advanced Imaging in HFpEF
NCT06905405 NOT_YET_RECRUITING